Cours Eidos Therapeutics, Inc.
Actions
EIDX
US28249H1041
Recherche biotechnologique et médicale
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Neil Kumar
CEO | Chief Executive Officer | 45 | 01/03/16 |
Jonathan Fox
PSD | President | 67 | 01/10/16 |
Uma Sinha
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/06/16 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Uma Sinha
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/06/16 |
Jonathan A. Barr
BRD | Director/Board Member | - | 26/01/21 |
Jonathan Fox
PSD | President | 67 | 01/10/16 |
Varia. 1 janv. | Capi. | |
---|---|---|
-3,10 % | 102 Md | |
+2,11 % | 96,07 Md | |
-1,80 % | 21,66 Md | |
-17,75 % | 20,77 Md | |
-6,91 % | 18,53 Md | |
-42,00 % | 16,91 Md | |
-28,19 % | 13,79 Md | |
+0,18 % | 13,33 Md | |
+19,90 % | 10,94 Md |